217 related articles for article (PubMed ID: 23401854)
81. Using a preclinical mouse model of high-grade astrocytoma to optimize p53 restoration therapy.
Shchors K; Persson AI; Rostker F; Tihan T; Lyubynska N; Li N; Swigart LB; Berger MS; Hanahan D; Weiss WA; Evan GI
Proc Natl Acad Sci U S A; 2013 Apr; 110(16):E1480-9. PubMed ID: 23542378
[TBL] [Abstract][Full Text] [Related]
82. Restoration of IRF1-dependent anticancer effects by MEK inhibition in human cancer cells.
AbuSara N; Razavi S; Derwish L; Komatsu Y; Licursi M; Hirasawa K
Cancer Lett; 2015 Feb; 357(2):575-81. PubMed ID: 25497010
[TBL] [Abstract][Full Text] [Related]
83. Physical and functional interaction of the p14ARF tumor suppressor with ribosomes.
Rizos H; McKenzie HA; Ayub AL; Woodruff S; Becker TM; Scurr LL; Stahl J; Kefford RF
J Biol Chem; 2006 Dec; 281(49):38080-8. PubMed ID: 17035234
[TBL] [Abstract][Full Text] [Related]
84. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
85. Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT.
Mirza AM; Gysin S; Malek N; Nakayama K; Roberts JM; McMahon M
Mol Cell Biol; 2004 Dec; 24(24):10868-81. PubMed ID: 15572689
[TBL] [Abstract][Full Text] [Related]
86. Signal Transduction in Ribosome Biogenesis: A Recipe to Avoid Disaster.
Piazzi M; Bavelloni A; Gallo A; Faenza I; Blalock WL
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31163577
[TBL] [Abstract][Full Text] [Related]
87. JHDM1B expression regulates ribosome biogenesis and cancer cell growth in a p53 dependent manner.
Penzo M; Casoli L; Pollutri D; Sicuro L; Ceccarelli C; Santini D; Taffurelli M; Govoni M; Brina D; Trerè D; Montanaro L
Int J Cancer; 2015 Mar; 136(5):E272-81. PubMed ID: 25273595
[TBL] [Abstract][Full Text] [Related]
88. Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation.
Itahana K; Bhat KP; Jin A; Itahana Y; Hawke D; Kobayashi R; Zhang Y
Mol Cell; 2003 Nov; 12(5):1151-64. PubMed ID: 14636574
[TBL] [Abstract][Full Text] [Related]
89. Mitogenic activity of estrogens in human breast cancer cells does not rely on direct induction of mitogen-activated protein kinase/extracellularly regulated kinase or phosphatidylinositol 3-kinase.
Gaben AM; Saucier C; Bedin M; Redeuilh G; Mester J
Mol Endocrinol; 2004 Nov; 18(11):2700-13. PubMed ID: 15297603
[TBL] [Abstract][Full Text] [Related]
90. The molecular scaffold kinase suppressor of Ras 1 is a modifier of RasV12-induced and replicative senescence.
Kortum RL; Johnson HJ; Costanzo DL; Volle DJ; Razidlo GL; Fusello AM; Shaw AS; Lewis RE
Mol Cell Biol; 2006 Mar; 26(6):2202-14. PubMed ID: 16507997
[TBL] [Abstract][Full Text] [Related]
91. Oncogenic MYC Induces the Impaired Ribosome Biogenesis Checkpoint and Stabilizes p53 Independent of Increased Ribosome Content.
Morcelle C; Menoyo S; Morón-Duran FD; Tauler A; Kozma SC; Thomas G; Gentilella A
Cancer Res; 2019 Sep; 79(17):4348-4359. PubMed ID: 31292158
[TBL] [Abstract][Full Text] [Related]
92. RNA helicase DHX33 regulates HMGB family genes in human cancer cells.
Wang X; Chen S; Wen F; Zeng Y; Zhang Y
Cell Signal; 2023 Oct; 110():110832. PubMed ID: 37543097
[TBL] [Abstract][Full Text] [Related]
93. Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate.
Brighenti E; Giannone FA; Fornari F; Onofrillo C; Govoni M; Montanaro L; Treré D; Derenzini M
Oncotarget; 2016 Sep; 7(39):63226-63241. PubMed ID: 27557515
[TBL] [Abstract][Full Text] [Related]
94. Ribosomes rule: translation, not transcription, is the primary target of two major intercellular signaling pathways.
Lasko P
Dev Cell; 2003 Nov; 5(5):671-2. PubMed ID: 14602068
[TBL] [Abstract][Full Text] [Related]
95. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.
Sato M; Vaughan MB; Girard L; Peyton M; Lee W; Shames DS; Ramirez RD; Sunaga N; Gazdar AF; Shay JW; Minna JD
Cancer Res; 2006 Feb; 66(4):2116-28. PubMed ID: 16489012
[TBL] [Abstract][Full Text] [Related]
96. DHX33 Recruits Gadd45a To Cause DNA Demethylation and Regulates a Subset of Gene Transcription.
Feng W; Chen S; Wang J; Wang X; Chen H; Ning W; Zhang Y
Mol Cell Biol; 2020 Jun; 40(13):. PubMed ID: 32312884
[TBL] [Abstract][Full Text] [Related]
97. Functional identification of LRF as an oncogene that bypasses RASV12-induced senescence via upregulation of CYCLIN E.
Vredeveld LC; Rowland BD; Douma S; Bernards R; Peeper DS
Carcinogenesis; 2010 Feb; 31(2):201-7. PubMed ID: 19942610
[TBL] [Abstract][Full Text] [Related]
98. DHX33 promotes colon cancer development downstream of Wnt signaling.
Zhu Y; Du Y; Zhang Y
Gene; 2020 Apr; 735():144402. PubMed ID: 32004669
[TBL] [Abstract][Full Text] [Related]
99. p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease.
Omura-Minamisawa M; Diccianni MB; Chang RC; Batova A; Bridgeman LJ; Schiff J; Cohn SL; London WB; Yu AL
Clin Cancer Res; 2001 Nov; 7(11):3481-90. PubMed ID: 11705866
[TBL] [Abstract][Full Text] [Related]
100. Regulation of ribosome biogenesis by the rapamycin-sensitive TOR-signaling pathway in Saccharomyces cerevisiae.
Powers T; Walter P
Mol Biol Cell; 1999 Apr; 10(4):987-1000. PubMed ID: 10198052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
